{"id":"https://openalex.org/W2061496437","doi":"https://doi.org/10.1517/13543784.2014.942729","title":"Phase II drugs that are currently in development for the treatment of cachexia","display_name":"Phase II drugs that are currently in development for the treatment of cachexia","alternate_titles":[],"publication_year":2014,"publication_date":"2014-07-24","ids":{"openalex":"https://openalex.org/W2061496437","doi":"https://doi.org/10.1517/13543784.2014.942729","mag":"2061496437","pmid":"https://pubmed.ncbi.nlm.nih.gov/25056249"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2014.942729","doi":"https://doi.org/10.1517/13543784.2014.942729","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.942729","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2061496437"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016567527","display_name":"Anne\u2010Marie C. Dingemans","orcid":"https://orcid.org/0000-0001-6105-182X","observed_orcids":["https://orcid.org/0000-0001-6105-182X","https://orcid.org/0000-0002-7069-6598"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne-Marie C Dingemans","raw_affiliation_strings":["Maastricht University Medical Center, Department of Respiratory Medicine , PO Box 5800, 6202 AZ Maastricht , The Netherlands +31 43 3871318 ; +31 43 3875051 ; a.dingemans @mumc.nl","Maastricht University Medical Center, Department of Respiratory Medicine,\nPO Box 5800, 6202 AZ Maastricht, The Netherlands +31 43 3871318","a.dingemans @mumc.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maastricht University Medical Center, Department of Respiratory Medicine , PO Box 5800, 6202 AZ Maastricht , The Netherlands +31 43 3871318 ; +31 43 3875051 ; a.dingemans @mumc.nl","institution_ids":["https://openalex.org/I2800191616"]},{"raw_affiliation_string":"Maastricht University Medical Center, Department of Respiratory Medicine,\nPO Box 5800, 6202 AZ Maastricht, The Netherlands +31 43 3871318","institution_ids":["https://openalex.org/I2800191616"]},{"raw_affiliation_string":"a.dingemans @mumc.nl","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031137165","display_name":"Judith de Vos\u2010Geelen","orcid":"https://orcid.org/0000-0003-2578-1766","observed_orcids":["https://orcid.org/0000-0003-2578-1766"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith de Vos-Geelen","raw_affiliation_strings":["Maastricht University Medical Center, Department of Medical Oncology, Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maastricht University Medical Center, Department of Medical Oncology, Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043038636","display_name":"RAMON C. J. LANGEN","orcid":"https://orcid.org/0000-0002-8622-3058","observed_orcids":["https://orcid.org/0000-0002-8622-3058"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ramon Langen","raw_affiliation_strings":["Maastricht University Medical Center, Department of Respiratory Medicine, Muscle Cell Biology, Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maastricht University Medical Center, Department of Respiratory Medicine, Muscle Cell Biology, Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013717261","display_name":"Annemie M.W.J. Schols","orcid":"https://orcid.org/0000-0001-9878-0428","observed_orcids":["https://orcid.org/0000-0001-9878-0428"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Annemie MW Schols","raw_affiliation_strings":["Maastricht University Medical Center, Department of Respiratory Medicine and Research institute NUTRIM, Maastricht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maastricht University Medical Center, Department of Respiratory Medicine and Research institute NUTRIM, Maastricht, The Netherlands","institution_ids":["https://openalex.org/I2800191616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800191616"],"apc_list":null,"apc_paid":null,"fwci":0.7194,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.53314659,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"12","first_page":"1655","last_page":"1669"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.022299999371170998,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10858","display_name":"Clinical Nutrition and Gastroenterology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cachexia","display_name":"cachexia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cancer-cachexia","display_name":"cancer cachexia","score":0.7419999837875366},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9190000295639038},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8410000205039978},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.8920000195503235},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.7540000081062317},{"id":"https://openalex.org/keywords/anabolic-agents","display_name":"anabolic agents","score":0.925000011920929},{"id":"https://openalex.org/keywords/muscle-atrophy","display_name":"muscle atrophy","score":0.6470000147819519},{"id":"https://openalex.org/keywords/dietary-intervention","display_name":"dietary intervention","score":0.75}],"concepts":[{"id":"https://openalex.org/C2777704314","wikidata":"https://www.wikidata.org/wiki/Q6003455","display_name":"Cachexia","level":3,"score":0.9207442998886108},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7584173083305359},{"id":"https://openalex.org/C2779764123","wikidata":"https://www.wikidata.org/wiki/Q7972881","display_name":"Wasting","level":2,"score":0.7141076922416687},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4742925465106964},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.4675148129463196},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.4465031921863556},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.44057878851890564},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4245871901512146},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.41233694553375244},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4102155566215515},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38644343614578247},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3295454978942871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30908745527267456},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.13755100965499878},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10417813062667847},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.07555210590362549}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1517/13543784.2014.942729","doi":"https://doi.org/10.1517/13543784.2014.942729","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2014.942729","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:25056249","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25056249","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire_cris_publications/5c779c3d-6c48-4cf6-bf82-c9504194b742","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/5c779c3d-6c48-4cf6-bf82-c9504194b742","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dingemans, A-M C, de Vos-Geelen, J, Langen, R & Schols, A M W 2014, 'Phase II drugs that are currently in development for the treatment of cachexia', Expert Opinion on Investigational Drugs, vol. 23, no. 12, pp. 1655-1669. https://doi.org/10.1517/13543784.2014.942729","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/5c779c3d-6c48-4cf6-bf82-c9504194b742","doi":null,"is_oa":false,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/5c779c3d-6c48-4cf6-bf82-c9504194b742","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Investigational Drugs, 23(12), 1655 - 1669. Routledge/Taylor &amp; Francis Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":88,"referenced_works":["https://openalex.org/W1490028331","https://openalex.org/W1569910817","https://openalex.org/W1600879661","https://openalex.org/W1757058093","https://openalex.org/W1880660232","https://openalex.org/W1908242390","https://openalex.org/W1964487553","https://openalex.org/W1966493407","https://openalex.org/W1968171821","https://openalex.org/W1968330239","https://openalex.org/W1968426286","https://openalex.org/W1969583687","https://openalex.org/W1971486155","https://openalex.org/W1972195365","https://openalex.org/W1975230416","https://openalex.org/W1975394584","https://openalex.org/W1977380331","https://openalex.org/W1977982006","https://openalex.org/W1979855377","https://openalex.org/W1980868512","https://openalex.org/W1983660080","https://openalex.org/W1985334791","https://openalex.org/W1985471058","https://openalex.org/W1985534077","https://openalex.org/W1988606404","https://openalex.org/W2001137830","https://openalex.org/W2003064100","https://openalex.org/W2003336155","https://openalex.org/W2005077354","https://openalex.org/W2005380415","https://openalex.org/W2007624126","https://openalex.org/W2012247976","https://openalex.org/W2016167725","https://openalex.org/W2016803682","https://openalex.org/W2018919870","https://openalex.org/W2021354449","https://openalex.org/W2034127653","https://openalex.org/W2034223186","https://openalex.org/W2038469310","https://openalex.org/W2038708549","https://openalex.org/W2041902534","https://openalex.org/W2052712443","https://openalex.org/W2054594032","https://openalex.org/W2057436385","https://openalex.org/W2067623537","https://openalex.org/W2068008235","https://openalex.org/W2072884377","https://openalex.org/W2073540860","https://openalex.org/W2075752626","https://openalex.org/W2077316345","https://openalex.org/W2081246610","https://openalex.org/W2082336326","https://openalex.org/W2085839997","https://openalex.org/W2086920509","https://openalex.org/W2092361675","https://openalex.org/W2094024997","https://openalex.org/W2095306624","https://openalex.org/W2100332558","https://openalex.org/W2102107385","https://openalex.org/W2107960666","https://openalex.org/W2108094230","https://openalex.org/W2111536564","https://openalex.org/W2113332979","https://openalex.org/W2115351357","https://openalex.org/W2116283917","https://openalex.org/W2116784557","https://openalex.org/W2119877173","https://openalex.org/W2120462386","https://openalex.org/W2123633897","https://openalex.org/W2127206464","https://openalex.org/W2127424726","https://openalex.org/W2130053803","https://openalex.org/W2132552005","https://openalex.org/W2140597408","https://openalex.org/W2143015711","https://openalex.org/W2145280166","https://openalex.org/W2149318570","https://openalex.org/W2151283204","https://openalex.org/W2152438927","https://openalex.org/W2160050642","https://openalex.org/W2161509070","https://openalex.org/W2163548319","https://openalex.org/W2169536980","https://openalex.org/W2325918023","https://openalex.org/W2330786025","https://openalex.org/W2917121126","https://openalex.org/W4205516870","https://openalex.org/W4313376856"],"related_works":["https://openalex.org/W2966280674","https://openalex.org/W2061005677","https://openalex.org/W2038469310","https://openalex.org/W1977785596","https://openalex.org/W4406186725","https://openalex.org/W1988688277","https://openalex.org/W7129236183","https://openalex.org/W2370661943","https://openalex.org/W4367834711","https://openalex.org/W1807248496"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Cachexia":[1,18],"is":[2,19,150],"a":[3],"syndrome":[4],"presenting":[5],"with":[6,52,131,147,197],"progressive":[7],"unintentional":[8],"weight":[9],"loss":[10],"and":[11,13,23,65,74,103,128,182],"wasting":[12],"weakness":[14],"of":[15,81,101,139,143,185,200],"skeletal":[16],"muscle.":[17,133],"prevalent":[20],"in":[21,24,119,162,195,209],"cancer":[22],"chronic":[25,28],"diseases":[26],"including":[27,55],"obstructive":[29],"pulmonary":[30],"disease":[31],"(COPD).":[32],"AREAS":[33],"COVERED:":[34],"The":[35,76,111],"authors":[36,77,97],"searched":[37],"trial":[38],"registers":[39],"for":[40],"current":[41],"Phase":[42,105],"II":[43,106],"clinical":[44],"trials":[45],"on":[46],"cachexia.":[47],"Twelve":[48],"studies":[49,83,158,175],"were":[50,90],"found":[51],"11":[53],"compounds,":[54],"the":[56,82,88,96,99,132,136,152,191,198,210],"anti-inflammatory":[57],"drugs":[58,146],"thalidomide,":[59],"OHR/AVR118,":[60],"celecoxib,":[61],"VT-122,":[62],"omega-3":[63],"supplements,":[64],"anabolic":[66,125],"agents":[67],"such":[68],"as":[69,165],"ghrelin":[70],"analogues,":[71],"MT-102,":[72],"BYM338":[73],"ruxolotinib.":[75],"note":[78],"that":[79],"one":[80],"related":[84,91],"to":[85,92,135,172],"COPD":[86],"while":[87],"others":[89],"different":[93],"cancers.":[94],"Herein,":[95],"describe":[98],"mechanisms":[100],"action":[102],"their":[104],"study":[107,114],"design.":[108],"EXPERT":[109],"OPINION:":[110],"compounds":[112],"under":[113],"affect":[115],"several":[116],"pathways":[117],"involved":[118],"cachexia":[120,140],"by":[121],"modulating":[122],"inflammatory":[123],"activity,":[124],"potential,":[126],"digestion":[127],"direct":[129],"interaction":[130],"Due":[134],"multifactorial":[137],"aspects":[138],"syndrome,":[141],"combinations":[142],"these":[144],"new":[145,188,206],"nutritional":[148],"intervention":[149],"probably":[151],"most":[153],"promising":[154],"approach.":[155],"Furthermore,":[156],"future":[157],"should":[159],"include":[160],"interventions":[161],"pre-cachetic":[163],"patients,":[164],"this":[166],"stage":[167],"might":[168],"be":[169],"more":[170],"responsive":[171],"treatment.":[173],"Future":[174],"will":[176,204],"benefit":[177],"from":[178],"well-defined":[179],"end":[180],"points":[181],"improved":[183],"measures":[184],"cachexia,":[186],"providing":[187],"insight":[189],"into":[190],"disease.":[192],"This":[193],"insight,":[194],"combination":[196],"elucidation":[199],"cachexia's":[201],"underlying":[202],"mechanism,":[203],"yield":[205],"treatment":[207],"strategies":[208],"near":[211],"future.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2061496437","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
